Susquehanna International Group, LLP Anavex Life Sciences Corp. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$4.11 - $7.04 $309,894 - $530,816	-75,400 Reduced 28.01%	193,800 $1.1 Million
Q2 2024 Aug 15, 2024	SELL	$3.39 - $5.02 $271,539 - $402,101	-80,100 Reduced 22.93%	269,200 $1.14 Million
Q1 2024 May 07, 2024	BUY	$4.55 - $6.75 $260,715 - $386,775	57,300 Added 19.62%	349,300 $1.78 Million
Q4 2023 Feb 14, 2024	SELL	$5.04 - $9.95 $1.52 Million - $3 Million	-301,700 Reduced 50.82%	292,000 $2.72 Million
Q3 2023 Nov 14, 2023	BUY	$6.55 - $9.37 $1.72 Million - $2.45 Million	261,900 Added 78.93%	593,700 $3.89 Million
Q2 2023 Aug 11, 2023	SELL	$7.66 - $9.5 $2.54 Million - $3.16 Million	-332,200 Reduced 50.03%	331,800 $2.7 Million
Q1 2023 May 16, 2023	BUY	$8.32 - $11.75 $1.69 Million - $2.39 Million	203,300 Added 44.13%	664,000 $5.69 Million
Q4 2022 Feb 14, 2023	SELL	$7.65 - $14.43 $459,765 - $867,243	-60,100 Reduced 11.54%	460,700 $4.27 Million
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $433,430 - $626,282	48,700 Added 10.32%	520,800 $5.38 Million
Q2 2022 Aug 15, 2022	SELL	$7.31 - $12.84 $962,727 - $1.69 Million	-131,700 Reduced 21.81%	472,100 $4.73 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $2.44 Million - $4.43 Million	250,700 Added 71.0%	603,800 $7.43 Million
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $2.65 Million - $3.66 Million	157,000 Added 80.06%	353,100 $6.12 Million
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $2.43 Million - $3.71 Million	-144,200 Reduced 42.37%	196,100 $3.52 Million
Q2 2021 Aug 11, 2021	SELL	$10.16 - $28.86 $1.98 Million - $5.63 Million	-195,200 Reduced 36.45%	340,300 $7.78 Million
Q1 2021 May 17, 2021	BUY	$5.17 - $16.13 $1.99 Million - $6.21 Million	385,100 Added 256.05%	535,500 $8.01 Million
Q4 2020 Feb 16, 2021	BUY	$4.01 - $7.58 $329,622 - $623,076	82,200 Added 120.53%	150,400 $812,000
Q3 2020 Nov 16, 2020	BUY	$3.8 - $5.0 $15,200 - $20,000	4,000 Added 6.23%	68,200 $310,000
Q4 2019 Feb 14, 2020	SELL	$2.31 - $3.14 $62,139 - $84,466	-26,900 Reduced 29.53%	64,200 $166,000
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.9 $107,004 - $187,980	48,200 Added 112.35%	91,100 $288,000
Q2 2019 Aug 14, 2019	BUY	$2.75 - $3.7 $88,000 - $118,400	32,000 Added 293.58%	42,900 $145,000
Q4 2018 Feb 14, 2019	SELL	$1.25 - $2.75 $50,375 - $110,825	-40,300 Reduced 78.71%	10,900 $17,000
Q3 2018 Nov 14, 2018	BUY	$2.23 - $3.82 $88,308 - $151,272	39,600 Added 341.38%	51,200 $140,000
Q2 2018 Aug 14, 2018	SELL	$2.08 - $4.26 $8,112 - $16,614	-3,900 Reduced 25.16%	11,600 $30,000
Q1 2018 May 15, 2018	SELL	$2.32 - $3.44 $28,303 - $41,968	-12,200 Reduced 44.04%	15,500 $43,000
Q3 2017 Nov 20, 2017	BUY	$3.42 - $4.87 $94,734 - $134,899	27,700	27,700 $115,000

Others Institutions Holding AVXL

# of Institutions

155

Shares Held

27.3M

Call Options Held

515K

Put Options Held

838K

Black Rock Inc. New York, NY

6.39M
Shares

$70.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.74M
Shares

$52.3 Million
0.0% of portfolio
State Street Corp Boston, MA

3.07M
Shares

$33.8 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.88M
Shares

$20.8 Million
0.0% of portfolio
Wealthgarden F.S. LLC El Segundo, CA

910K
Shares

$10.1 Million
0.32% of portfolio

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $860M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account